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Relationships between dairy products and cardiovascular risk are debated.
On the one hand, saturated fats contained in dairy products have a deleterious
impact on lipids. On the other hand, dietary calcium has been shown to lower
blood pressure and to be associated with a reduced occurrence of metabolic
syndrome and obesity. 
Aim: To investigate the link between dairy product intake and all-cause
death in a cohort followed over 12 years.
Methods: A sample of 947 men aged 45-64 was randomly selected in
1995-96 from the general population of Lille, Strasbourg and Toulouse areas.
Each participant completed a 3-day food record, checked by a dietician. Vital
status was obtained on December 31, 2009.
Results: Median follow-up was 13.8 years. Cumulative incidence of death
reached 13.3%, with a significant north-south gradient (21.4% in Lille, 10.2%
in Strasbourg, and 7.4% in Toulouse). People who died were significantly
older, had less often graduated from high school, were preferentially farmers,
employees or workers, less often liable to income tax, and more often heavy
smokers or sedentary people. They consumed a lower amount of vegetable
proteins, polysaccharides, polyunsaturated fats, linoleic acid, milk and dairy
products, but a higher amount of alcohol. Compared to people who did not
drink milk, the relative risk of death was 0.64 [(95% CI: 0.42-0.98); p=0.038]
in those consuming up to one glass per day (250 ml) and 0.45 [(0.22-0.94);
p=0.032] for more than one glass, after adjustment for centre, age, high school
completion, job category, liability for income tax, severe chronic disease,
Framingham risk score, alcohol intake, smoking, physical activity, food
quality index, and calorie intake. Other dairy products were not significantly
associated with death.
Conclusion: Drinking milk is associated with a reduced risk of all-cause
death, independently of main confounders such as age, poor diet quality or
health conditions, and educational and socio-economic status. 
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Background: Likelihood of coronary artery disease (CAD) is based on
predictive models that have been developed in early 70’s in North America.
It’s unknown whether those models are accurate in European populations.
Methods: In two regional centers recruiting urban and peri-urban Southern
French population, patients with suspected CAD were prospectively referred
to Coronary Computed Tomography (CCT) with a 64-slice scan. Inclusion cri-
teria were 1 – clinically suspected angina pectoris or 2 – suspected silent
ischemia on resting EKG. Significant CAD was defined as at least one coro-
nary artery with lumen stenosis >50% by CCT. Likelihood of significant CAD
was estimated using the Duke Model. Predictive quality of the model was
assessed: reliability by comparing the predicted likelihood with the observed
proportion of CAD, and discrimination by comparing the distribution of like-
lihood of significant CAD according to the CAD status and estimating the
c-index of the model. Coefficients associated to the predictive characteristics
presented in the Duke Model were estimated among the included patients.
Results: Out of 824 patients, CCT imaging was adequate in 737 and sig-
nificant CAD was detected in 227 patients (31%). Observed proportion of
patients with significant CAD was lower than the predicted probability
(mainly explained by the change in the expected slope, Graph). Mean pre-
dicted likelihood of significant CAD was 0.48±0.27 and 0.72±0.22 among
patients without and with significant CAD, respectively (p<0.0001). The c-
index was equal to 0.75 (95% CI, 071 to 0.78). Estimates of coefficients of
the characteristics presented in the Duke model varied substantially among our
patients.
Conclusions: The assessment of the quality of predictions of the Duke
model for significant CAD showed an imperfect reliability in our study popu-
lation. Specific predictive models are needed to estimate likelihood of CAD in
Southern France.
314
Adiponectin and long term mortality in coronary heart disease
patients according to the severity of the disease
Sébastien Hascoet [Orateur] (1), Meyer Elbaz (2), Vanina Bongard (3),
Frédéric Bouisset (1), Bertrand Perret (4), Michel Galinier (1), Didier Car-
rié (2), Jean Carrié (5), Jean-Bernard Ruidavets (6)
(1) CHU Toulouse, Cardiologie A, Toulouse, France – (2) CHU Toulouse,
Cardiologie B, Toulouse, France – (3) CHU Toulouse, Epidémiologie,
Inserm U1027, Toulouse, France – (4) CHU La Grave, Inserm U563, Bio-
chimie, Toulouse, France – (5) CHU Rangueil, Cardiologie B, Toulouse,
France – (6) CHU Toulouse, Epidémiologie, Inserm U1027, Toulouse,
France
Background: Adiponectin is an hormone secreted by the adipose tissue
that is implied in the regulation of glucose and fatty acids metabolism. We
aimed to investigate in French men with CHD whether plasma adiponectin
levels are associated with long-term mortality, considering varying degrees of
CHD severity.
Methods: Among 834 consecutive men (45-74 years) hospitalized for
CHD between 2001 and 2004, total plasma adiponectin measured by ELISA
and markers of CHD severity (Gensini and Jeopardy scores, resting heart rate
(RHR) and left ventricular dysfunction (LVEF)) were assessed in 736 patients
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